Ubs Group Ag Ionis Pharmaceuticals Inc Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Group Ag holds 152,672 shares of IONS stock, worth $5.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,672

Previous 171,763 11.11%

Holding current value

$5.96 Million

Previous $7.45 Million 2.27%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $695,866 - $910,640	-19,091 Reduced 11.11%	152,672 $7.28 Million
Q1 2024 May 13, 2024	BUY	$42.03 - $53.55 $505,368 - $643,885	12,024 Added 7.53%	171,763 $7.45 Million
Q4 2023 Feb 09, 2024	BUY	$43.39 - $51.63 $2.2 Million - $2.62 Million	50,705 Added 46.5%	159,739 $8.08 Million
Q3 2023 Nov 09, 2023	BUY	$38.5 - $47.13 $624,046 - $763,930	16,209 Added 17.46%	109,034 $4.95 Million
Q2 2023 Aug 11, 2023	SELL	$34.73 - $43.33 $282,042 - $351,882	-8,121 Reduced 8.04%	92,825 $3.81 Million
Q1 2023 May 12, 2023	SELL	$33.58 - $41.2 $2.03 Million - $2.49 Million	-60,525 Reduced 37.48%	100,946 $3.61 Million
Q4 2022 Feb 08, 2023	BUY	$37.12 - $46.52 $3.72 Million - $4.66 Million	100,161 Added 163.37%	161,471 $6.1 Million
Q3 2022 Nov 10, 2022	SELL	$36.54 - $48.66 $3.98 Million - $5.3 Million	-108,857 Reduced 63.97%	61,310 $2.71 Million
Q2 2022 Aug 10, 2022	SELL	$31.71 - $43.0 $984,088 - $1.33 Million	-31,034 Reduced 15.42%	170,167 $6.3 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $227,446 - $281,948	7,612 Added 3.93%	201,201 $7.45 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $1.56 Million - $2.13 Million	60,777 Added 45.76%	193,589 $5.89 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $748,512 - $904,954	-22,317 Reduced 14.39%	132,812 $4.46 Million
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $4.35 Million - $5.96 Million	126,067 Added 433.79%	155,129 $6.19 Million
Q1 2021 May 12, 2021	SELL	$42.51 - $63.78 $1.84 Million - $2.76 Million	-43,258 Reduced 59.81%	29,062 $1.31 Million
Q4 2020 Feb 11, 2021	SELL	$45.3 - $60.27 $1.66 Million - $2.21 Million	-36,608 Reduced 33.61%	72,320 $4.09 Million
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $2.86 Million - $3.79 Million	60,169 Added 123.4%	108,928 $5.17 Million
Q2 2020 Jul 31, 2020	SELL	$46.85 - $61.05 $1.98 Million - $2.59 Million	-42,344 Reduced 46.48%	48,759 $2.87 Million
Q1 2020 May 01, 2020	SELL	$41.6 - $63.4 $2.39 Million - $3.64 Million	-57,367 Reduced 38.64%	91,103 $4.31 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $4.34 Million - $5.26 Million	-80,655 Reduced 35.2%	148,470 $8.97 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $4.94 Million - $6.04 Million	83,646 Added 57.5%	229,125 $13.7 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $2.53 Million - $3.52 Million	40,817 Added 39.0%	145,479 $9.35 Million
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $3.6 Million - $5.53 Million	-68,076 Reduced 39.41%	104,662 $8.5 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $3.01 Million - $4.14 Million	69,474 Added 67.28%	172,738 $9.34 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $1.07 Million - $1.33 Million	24,841 Added 31.68%	103,264 $5.33 Million
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $4.18 Million - $5.23 Million	-103,133 Reduced 56.81%	78,423 $3.27 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $4.02 Million - $5.02 Million	91,187 Added 100.91%	181,556 $8 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $1.52 Million - $1.95 Million	-30,277 Reduced 25.1%	90,369 $4.55 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $2.4 Million - $3.14 Million	52,681 Added 77.51%	120,646 $6.12 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-39,039 Reduced 36.48%	67,965 $3.46 Million
Q1 2017 Nov 14, 2017	BUY	N/A	107,004	107,004 $4.3 Million

Others Institutions Holding IONS

# of Institutions

394

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.55B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account